Literature DB >> 6491095

Natural history of large local reactions from stinging insects.

P M Mauriello, S H Barde, J W Georgitis, R E Reisman.   

Abstract

In ongoing studies of the natural history of stinging-insect allergy, 133 patients with large local reactions have been evaluated over 8 yr; 79 patients returned for reevaluation. Based on RAST analysis with honeybee and vespid venoms, patients were divided into RAST-positive and RAST-negative groups. Sixty-six patients were RAST-negative with positive venom skin tests in 58%. Seventy-five testings in this group led to no systemic reactions and 74 large local reactions. At follow-up RASTs remained negative, and the incidence of positive skin tests was unchanged. Sixty-seven patients had detectable serum venom-specific IgE covering a wide range in antibody titers, indistinguishable from patients with systemic reactions. Twenty-four of 67 patients received venom immunotherapy (VIT). RAST titers decreased similarly in the VIT and untreated groups. There were 55 testings resulting in 40 recurrent large local reactions occurring in equal incidence in treated and untreated patients. One systemic reaction occurred in an untreated patient. In reviewing 118 patients with sting anaphylaxis, a previous large local reaction occurred in five. These results suggest that after repeat stings, patients with large local reactions tend to have subsequent large local reactions, regardless of the presence of venom-specific IgE or immunotherapy. There is small risk of anaphylaxis. Determination of serum venom-specific IgE by RAST or skin tests does not aid in treatment or in predicting prognosis. Thus skin tests are not necessary in patients who have had large local reactions, and venom immunotherapy is not indicated.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6491095     DOI: 10.1016/0091-6749(84)90384-1

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  16 in total

Review 1.  How should allergists deal with local reactions to allergen immunotherapy?

Authors:  Michael S Tankersley
Journal:  Curr Allergy Asthma Rep       Date:  2011-04       Impact factor: 4.806

2.  Venom immunotherapy for stinging insect allergy.

Authors:  D F Graft
Journal:  Clin Rev Allergy       Date:  1987-05

3.  Diagnosis and prevalence of stinging insect allergy.

Authors:  D B Golden
Journal:  Clin Rev Allergy       Date:  1987-05

Review 4.  Hymenoptera (apid and vespid) allergy: update in diagnosis and management.

Authors:  Gerald W Volcheck
Journal:  Curr Allergy Asthma Rep       Date:  2002-01       Impact factor: 4.806

5.  [Increasing incidence of wasp stings in otorhinolaryngological practice].

Authors:  P P Caffier; T Schrom; H Haupt; B Mazurek
Journal:  HNO       Date:  2006-06       Impact factor: 1.284

6.  Consensus Guidelines on Practical Issues of Immunotherapy-Canadian Society of Allergy and Clinical Immunology (CSACI).

Authors:  Eric Leith; Tom Bowen; Joe Butchey; David Fischer; Harold Kim; Bill Moote; Peter Small; Don Stark; Susan Waserman
Journal:  Allergy Asthma Clin Immunol       Date:  2006-06-15       Impact factor: 3.406

Review 7.  Insect sting anaphylaxis.

Authors:  David B K Golden
Journal:  Immunol Allergy Clin North Am       Date:  2007-05       Impact factor: 3.479

Review 8.  Allergen-specific immunotherapy of Hymenoptera venom allergy - also a matter of diagnosis.

Authors:  Maximilian Schiener; Anke Graessel; Markus Ollert; Carsten B Schmidt-Weber; Simon Blank
Journal:  Hum Vaccin Immunother       Date:  2017-06-12       Impact factor: 3.452

Review 9.  Stinging insect allergy: current perspectives on venom immunotherapy.

Authors:  Sian W Ludman; Robert J Boyle
Journal:  J Asthma Allergy       Date:  2015-07-23

10.  Risk of anaphylaxis in patients with large local reactions to hymenoptera stings: a retrospective and prospective study.

Authors:  Stefano Pucci; Simona D'Alò; Tiziana De Pasquale; Ilenia Illuminati; Elena Makri; Cristoforo Incorvaia
Journal:  Clin Mol Allergy       Date:  2015-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.